PET/MRI in head and neck cancer: Initial experience

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 1, 2013, Pages 6-11

  Platzek, Ivan ^a   Beuthien Baumann, Bettina ^a   Schneider, Matthias ^a   Gudziol, Volker ^a   Langner, Jens ^b   Schramm, Georg ^b   Laniado, Michael ^a   Kotzerke, Jörg ^a   Van Den Hoff, Jörg ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Head and neck cancer; PET MRI

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; ARTIFACT; CANCER PATIENT; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG UPTAKE; FEASIBILITY STUDY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; WHOLE BODY SCANNER; WHOLE BODY SCINTISCANNING;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; WHOLE BODY IMAGING;

EID: 84875740800     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2248-z     Document Type: Article

References (27)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917. doi: 10.1002/ijc.25516.
2. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21:194-200. doi: 10.1097/CCO.0b013e32832a68ca.
3. Johnson JT. A surgeon looks at cervical lymph nodes. Radiology. 1990;175:607-10.
4. Ong CK, Chong VF. Imaging of tongue carcinoma. Cancer Imaging. 2006;6:186-93. doi: 10.1102/1470-7330.2006.0029.
5. Kosling S, Knipping S, Hofmockel T. Imaging of nasopharyngeal diseases. HNO. 2009;57:813-24. doi: 10.1007/s00106-009-1966-4. quiz 25.
6. Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005;46:1136-43.
7. Hannah A, Scott AM, Tochon-Danguy H, et al. Evaluation of 18F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg. 2002;236:208-17. doi: 10.1097/01.SLA.0000021592.90987.AA.
8. Ng SH, Yen TC, Chang JT, et al. Prospective study of [18F] fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006;24:4371-6. doi: 10.1200/JCO.2006.05.7349.
9. Zaidi H, Ojha N, Morich M, et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol. 2011;56:3091-106. doi: 10.1088/0031-9155/56/10/013.
10. Fuechtner F, Steinbach J, Maeding P, Johannsen B. Basic hydrolysis of 2-[18F]fluoro-1,3,4,6-tetra-O-acetyl-D-glucose in the preparation of 2-[18F]fluoro-2-deoxy-D-glucose. Appl Radiat Isot. 1996;47:61-6.
11. Schulz V, Torres-Espallardo I, Renisch S, et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging. 2011;38:138-52. doi: 10.1007/s00259-010-1603-1.
12. Schramm G, Langner J, Hofheinz F, Petr J, Beuthien-Baumann B, Platzek I. Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction. MAGMA. 2012. doi: 10.1007/s10334-012-0328-5.
13. van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990;177:379-84.
14. Steinkamp HJ, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R. Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol. 1995;68:266-70.
15. King AD, Tse GM, Ahuja AT, et al. Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US. Radiology. 2004;230:720-6. doi: 10.1148/radiol.2303030157.
16. de Bondt RB, Nelemans PJ, Bakers F, et al. Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes. Eur Radiol. 2009;19:626-33. doi: 10.1007/s00330-008-1187-3.
17. Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg. 2000;28:319-24. doi: 10.1054/jcms.2000.0172.
18. Hofheinz F, Potzsch C, Oehme L, Beuthien-Baumann B, Steinbach J, Kotzerke J, et al. Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin. 2012;51:9-16. doi: 10.3413/Nukmed-0419-11-07.
19. Boss A, Stegger L, Bisdas S, Kolb A, Schwenzer N, Pfister M. Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol. 2011;21:1439-46. doi: 10.1007/s00330-011-2072-z.
20. Boss A, Bisdas S, Kolb A, et al. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med. 2010;51:1198-205. doi: 10.2967/jnumed.110.074773.
21. Lois C, Jakoby BW, Long MJ, et al. An assessment of the impact of incorporating time-of-flight information into clinical PET/CT imaging. J Nucl Med. 2010;51:237-45. doi: 10.2967/jnumed.109.068098.
22. Spanoudaki VC, Levin CS. Photo-detectors for time of flight positron emission tomography (ToF-PET). Sensors (Basel). 2010;10:10484-505. doi: 10.3390/S101110484.
23. Szczesniak T, Moszynski M, Swiderski L, Nassalski A, Lavoute P, Kapusta M. Fast photomultipliers for TOF PET. IEEE Trans Nucl Sci. 2009;56:173-81. doi: 10.1109/Tns.2008.2008992.
24. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med. 1999;26:1345-8.
25. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371-88. doi: 10.1002/ana.410060502.
26. Nakamoto Y, Osman M, Cohade C, et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med. 2002;43:1137-43.
27. Souvatzoglou M, Ziegler SI, Martinez MJ, et al. Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET. Eur J Nucl Med Mol Imaging. 2007;34:405-12. doi: 10.1007/s00259-006-0196-1.